Abstract P014: Clinically Significant Novel Biomarkers for Prediction of First-ever Myocardial Infarction-The Tromsø Study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Circulation

• Publication date

  2014-03-25

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Suppression of CSF2RA macrophage polarisation impacts pathological cardiac remodelling in mice

  2026cites this paper
• Circulating miR‐133a‐3p and miR‐451a as potential biomarkers for diagnosis of coronary artery disease

  2024cites this paper
• Lipoprotein(a) and the pooled cohort equations for ASCVD risk prediction: The Multi-Ethnic Study of Atherosclerosifs.

  2023cites this paper
• Deep Learning Improves Prediction of Cardiovascular Disease-Related Mortality and Admission in Patients with Hypertension: Analysis of the Korean National Health Information Database

  2022cites this paper
• Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages

  2020cites this paper
• The role of thrombospondin-4 in cardiovascular diseases

  2020cites this paper
• Using proximity extension proteomics assay to identify biomarkers associated with infarct size and ejection fraction after ST-elevation myocardial infarction

  2020cites this paper
• Longitudinal Plasma Kallikrein Levels and Their Association With the Risk of Cardiovascular Disease Outcomes in Type 1 Diabetes in DCCT/EDIC

  2020cites this paper
• The P387 thrombospondin‐4 variant promotes accumulation of macrophages in atherosclerotic lesions

  2020cites this paper
• Effect of Thrombospondin-4 on Pro-inflammatory Phenotype Differentiation and Apoptosis in Macrophages

  2019cites this paper
• ApoB/ApoA1 ratio and non-HDL-cholesterol/HDL-cholesterol ratio are associated to metabolic syndrome in patients with type 2 diabetes mellitus subjects and to ischemic cardiomyopathy in diabetic women.

  2019cites this paper
• The P387 Thrombospondin-4 Variant Promotes Accumulation of Macrophages in Atherosclerotic Lesions

  2019influential citation
• Novel Approaches to Cardiovascular Diagnostics: Focus on Coronary Artery Disease and Myocardial Infarction

  2018cites this paper
• Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism

  2018cites this paper
• The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction

  2018cites this paper
• Association of fetuin-A with incident type 2 diabetes: results from the MONICA/KORA Augsburg study and a systematic meta-analysis.

  2018cites this paper
• Adverse lipid profile elevates risk for subarachnoid hemorrhage: A prospective population-based cohort study.

  2018cites this paper
• Cytokines as therapeutic agents and targets in heart disease.

  2018cites this paper
• Circulating Levels of Interleukin 1-Receptor Antagonist and Risk of Cardiovascular Disease: Meta-Analysis of Six Population-Based Cohorts

  2017cites this paper
• Thrombospondin-4 in tissue remodeling.

  2017cites this paper
• Systemic inflammatory impact of periodontitis on acute coronary syndrome.

  2016cites this paper
• Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins

  2016cites this paper
• Exomes, Proteins, and Cardiovascular Disease: Making Sense of the Signals.

  2016cites this paper
• The Tromsø study 1974–2016: 40 years of cardiovascular research

  2016cites this paper
• Biomarker Testing in Risk Assessment and Management of Cardiovascular Disease

  year unknowncites this paper